Cargando…

Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach

COVID-19, the disease caused by SARS-CoV-2, has been declared as a global pandemic. Traditional medicinal plants have long history to treat viral infections. Our in silico approach suggested that unique phytocompounds such as emodin, thymol and carvacrol, and artemisinin could physically bind SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolta, Rajan, Salaria, Deeksha, Sharma, PremPrakash, Sharma, Bhanu, Kumar, Vikas, Rathi, Brijesh, Verma, Mansi, Sourirajan, Anuradha, Baumler, David J., Dev, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279807/
https://www.ncbi.nlm.nih.gov/pubmed/34306988
http://dx.doi.org/10.1007/s40495-021-00259-4
_version_ 1783722519810801664
author Rolta, Rajan
Salaria, Deeksha
Sharma, PremPrakash
Sharma, Bhanu
Kumar, Vikas
Rathi, Brijesh
Verma, Mansi
Sourirajan, Anuradha
Baumler, David J.
Dev, Kamal
author_facet Rolta, Rajan
Salaria, Deeksha
Sharma, PremPrakash
Sharma, Bhanu
Kumar, Vikas
Rathi, Brijesh
Verma, Mansi
Sourirajan, Anuradha
Baumler, David J.
Dev, Kamal
author_sort Rolta, Rajan
collection PubMed
description COVID-19, the disease caused by SARS-CoV-2, has been declared as a global pandemic. Traditional medicinal plants have long history to treat viral infections. Our in silico approach suggested that unique phytocompounds such as emodin, thymol and carvacrol, and artemisinin could physically bind SARS-CoV-2 spike glycoproteins (6VXX and 6VYB), SARS-CoV-2 B.1.351 South Africa variant of Spike glycoprotein (7NXA), and even with ACE2 and prevent the SARS-CoV-2 binding to the host ACE2, TMPRSS2 and neutrapilin-1 receptors. Since Chloroquine has been looked as potential therapy against COVID-19, we also compared the binding of chloroquine and artemisinin for its interaction with spike proteins (6VXX, 6VYB) and its variant 7NXA, respectively. Molecular docking study of phytocompounds and SARS-CoV-2 spike protein was performed by using AutoDock/Vina software. Molecular dynamics (MD) simulation was performed for 50ns. Among all the phytocompounds, molecular docking studies revealed lowest binding energy of artemisinin with 6VXX and 6VYB, with E(total) −10.5 KJ mol(−1) and −10.3 KJ mol(−1) respectively. Emodin showed the best binding affinity with 6VYB with E(total) −8.8 KJ mol(−1)and SARS-CoV-2 B.1.351 variant (7NXA) with binding energy of −6.4KJ mol(−1). Emodin showed best interactions with TMPRSS 2 and ACE2 with E(total) of −7.1 and −7.3 KJ mol(−1) respectively, whereas artemisinin interacts with TMPRSS 2 and ACE2 with E(total) of −6.9 and −7.4 KJ mol(−1) respectively. All the phytocompounds were non-toxic and non-carcinogenic. MD simulation showed that artemisinin has more stable interaction with 6VYB as compared to 6VXX, and hence proposed as potential phytochemical to prevent SARS-CoV-2 interaction with ACE-2 receptor. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40495-021-00259-4.
format Online
Article
Text
id pubmed-8279807
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82798072021-07-19 Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach Rolta, Rajan Salaria, Deeksha Sharma, PremPrakash Sharma, Bhanu Kumar, Vikas Rathi, Brijesh Verma, Mansi Sourirajan, Anuradha Baumler, David J. Dev, Kamal Curr Pharmacol Rep Natural Products: From Chemistry to Pharmacology (C Ho, Section Editor) COVID-19, the disease caused by SARS-CoV-2, has been declared as a global pandemic. Traditional medicinal plants have long history to treat viral infections. Our in silico approach suggested that unique phytocompounds such as emodin, thymol and carvacrol, and artemisinin could physically bind SARS-CoV-2 spike glycoproteins (6VXX and 6VYB), SARS-CoV-2 B.1.351 South Africa variant of Spike glycoprotein (7NXA), and even with ACE2 and prevent the SARS-CoV-2 binding to the host ACE2, TMPRSS2 and neutrapilin-1 receptors. Since Chloroquine has been looked as potential therapy against COVID-19, we also compared the binding of chloroquine and artemisinin for its interaction with spike proteins (6VXX, 6VYB) and its variant 7NXA, respectively. Molecular docking study of phytocompounds and SARS-CoV-2 spike protein was performed by using AutoDock/Vina software. Molecular dynamics (MD) simulation was performed for 50ns. Among all the phytocompounds, molecular docking studies revealed lowest binding energy of artemisinin with 6VXX and 6VYB, with E(total) −10.5 KJ mol(−1) and −10.3 KJ mol(−1) respectively. Emodin showed the best binding affinity with 6VYB with E(total) −8.8 KJ mol(−1)and SARS-CoV-2 B.1.351 variant (7NXA) with binding energy of −6.4KJ mol(−1). Emodin showed best interactions with TMPRSS 2 and ACE2 with E(total) of −7.1 and −7.3 KJ mol(−1) respectively, whereas artemisinin interacts with TMPRSS 2 and ACE2 with E(total) of −6.9 and −7.4 KJ mol(−1) respectively. All the phytocompounds were non-toxic and non-carcinogenic. MD simulation showed that artemisinin has more stable interaction with 6VYB as compared to 6VXX, and hence proposed as potential phytochemical to prevent SARS-CoV-2 interaction with ACE-2 receptor. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40495-021-00259-4. Springer International Publishing 2021-07-15 2021 /pmc/articles/PMC8279807/ /pubmed/34306988 http://dx.doi.org/10.1007/s40495-021-00259-4 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Natural Products: From Chemistry to Pharmacology (C Ho, Section Editor)
Rolta, Rajan
Salaria, Deeksha
Sharma, PremPrakash
Sharma, Bhanu
Kumar, Vikas
Rathi, Brijesh
Verma, Mansi
Sourirajan, Anuradha
Baumler, David J.
Dev, Kamal
Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
title Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
title_full Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
title_fullStr Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
title_full_unstemmed Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
title_short Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
title_sort phytocompounds of rheum emodi, thymus serpyllum, and artemisia annua inhibit spike protein of sars-cov-2 binding to ace2 receptor: in silico approach
topic Natural Products: From Chemistry to Pharmacology (C Ho, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279807/
https://www.ncbi.nlm.nih.gov/pubmed/34306988
http://dx.doi.org/10.1007/s40495-021-00259-4
work_keys_str_mv AT roltarajan phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT salariadeeksha phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT sharmapremprakash phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT sharmabhanu phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT kumarvikas phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT rathibrijesh phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT vermamansi phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT sourirajananuradha phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT baumlerdavidj phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach
AT devkamal phytocompoundsofrheumemodithymusserpyllumandartemisiaannuainhibitspikeproteinofsarscov2bindingtoace2receptorinsilicoapproach